Baird Financial Group, Inc. Pacira Bio Sciences, Inc. Transaction History

Baird Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $235,510 - $308,926	-6,440 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$36.47 - $42.17 $238,513 - $275,791	-6,540 Reduced 50.39%	6,440 $245,000
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $287,063 - $362,459	6,949 Added 115.22%	12,980 $558,000
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $198,118 - $313,612	6,031 New	6,031 $288,000
Q1 2018 May 14, 2018	SELL	$29.98 - $46.35 $173,704 - $268,551	-5,794 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$31.85 - $46.95 $1,114 - $1,643	-35 Reduced 0.6%	5,794 $264,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $16,921 - $18,723	474 Added 8.85%	5,829 $219,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,355	5,355 $255,000

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.21B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.